Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00174486 | Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction | PHASE2 | COMPLETED | 300 | — | — | Feb 1, 2005 | Jun 1, 2005 | Jul 25, 2006 | - | — |
| Name | Type | Description |
|---|---|---|
| UK0369,003 | DRUG | - |
| Cialis (Tadalafil) | DRUG | - |
Inclusion Criteria: * Erectile Dysfunction Exclusion Criteria: * Alpha blockers and Nitrates of any preparation